Profound Medical Cash Flow Statement (2022-2026) | PROF

Cash Flow Statement Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -6.58M-6.92M-9.37M23.19M-10.72M-15.71M-7.98M-8.16M-7.05M
Depreciation and Depletion (Quarter) 0.20M0.18M0.16M0.16M0.12M0.10M0.09M0.06M0.09M
Share-based Compensation (Quarter) 0.77M0.77M0.60M0.44M0.99M1.45M1.67M1.38M1.05M
Deferred Taxes (Quarter) 0.00M
Gains from Sales and Divestitures (Quarter) 0.01M0.01M0.01M0.01M0.01M0.17M0.01M
Gains from Investment Securities (Quarter) 1.51M1.47M0.01M0.16M0.04M2.29M0.01M0.05M0.23M2.14M0.03M
Non-cash Items (Quarter) 1.22M1.33M1.17M1.19M1.17M1.41M1.46M
Cash from Operations (Quarter) -4.53M-6.22M-6.83M-5.88M-8.28M-13.74M-9.61M-6.57M-8.58M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.05M0.05M0.05M0.08M0.05M0.04M0.05M0.05M0.01M
Depreciation & Amortization (CF) (Quarter) 0.20M0.18M0.16M0.16M0.12M0.10M0.09M0.06M0.09M
Change in Working Capital
Change in Receivables (Quarter) -1.32M0.84M-0.30M0.59M-1.09M-1.36M3.36M-0.74M2.24M
Change in Inventory (Quarter) 0.18M-0.01M-0.34M-0.48M0.98M1.74M-0.13M0.23M1.00M
Change in Accured Expenses (Quarter) -0.57M0.06M0.68M0.65M0.30M0.24M-0.21M0.04M0.31M
Change in Taxes (Quarter) 0.01M-0.02M0.00M
Other Working Capital Changes (Quarter) -0.11M0.12M0.05M-1.01M0.25M0.07M-0.22M0.27M0.09M
Financing Activities
Other financing activities (Quarter) 1.86M-0.41M1.54M3.04M0.09M0.07M0.07M
Cash from Financing Activities (Quarter) 20.46M-0.60M-0.59M35.44M-0.29M41.43M
Additional items
Exchange Rate Effect (Quarter) -0.96M-0.28M0.46M-1.77M0.09M2.51M-0.76M0.28M-0.84M
Change in Cash (Quarter) 15.93M-6.82M-7.42M29.56M-8.57M-13.74M-9.61M34.62M-8.58M
Free Cash Flow (Quarter) -4.53M-6.22M-6.83M-5.88M-8.28M-13.74M-9.61M-6.57M-8.58M
Net Cash Flow (Quarter) 15.93M-6.82M-7.42M29.56M-8.57M-13.74M-9.61M34.86M-8.58M